NEW YORK (GenomeWeb News) – Danaher said yesterday that it has acquired and received acceptances for approximately 97 percent of the currently issued shares of Genetix Group.

Danaher said that it intends to acquire any common shares of Genetix that remain untendered through the compulsory acquisition provisions for UK companies.

In December, Danaher, based in Washington, DC, offered to buy New Milton, UK-based Genetix Group for around ₤63.4 million ($102 million), or 85 pence per share.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.